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CRH gene expression in the fetal rat is not increased after pharmacological 
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A regimen of twice daily metyrapone i j ctions (100 mg/kg), resulted in pharmacological adrenalectomy of pregnant rats nd fetuses inutero, i.e. 
depression of plasma corticosterone and elevation of plasma drenocorlicotropic hormone (ACTH). Toxicity was minimal on days 14 17 of 
pregnancy, and increased with higher maternal weight and pregnancy progression. Corticotropin releasing hormone (CRH) messenger RNA abun- 
dance in the pregnant adults increased significantly within 48 h of metyrapone initiation. No change in CRH gene xpression i  the paraventricular 
nucleus of fetuses (days 17 18) was seen, even alter 72 h of the regimen. This i  compatible with the independence o1"CRH gene expression of 
glucocorticoid feedback inthe fetal rat. 
The mechanisms controlling corticotropin releasing 
hormone (CRH) gene expression in the developing rat 
brain have not been defined. The onset of messenger 
RNA (CRH-mRNA)  synthesis occurs on the 17th fetal 
day, and after increasing in the late fetal period, de- 
creases markedly around the time of birth [2, 7]. Whether 
the onset and the hiatus in CRH gene expression are 
intrinsic, constitutively regulated phenomena, or are 
modulated via negative feedback by circulating adreno- 
corticotropic hormone (ACTH) or corticosterone, is un- 
known. This study was designed to examine the effects of 
eliminating the negative corticosterone (CORT) feed- 
back on the brain-adrenal axis in the fetal rat. Our goal 
was to study the effects of functional fetal adrenalectomy 
on CRH gene expression in the fetal rat, in comparison 
with the pregnant adult. 
Forty timed-pregnancy Sprague Dawley derived rats, 
weighing less than 350 g, were kept on a 12 h light/dark 
cycle and allowed unlimited access to lab chow and 
water. Pregnancy was dated by the presence of a vaginal 
plug (day 0). Gestation lasted for 21 days. Pharmacologi- 
cal adrenalectomy schedule [14] was started on the 14th- 
18th day of pregnancy, and continued for 48 or 72 h, as 
previously described [4]. Briefly, pregnant rats were in- 
jected subcutaneously with dimethylsulfoxide (DMSO) 
('orre~v~ondence: T.Z. Baram, Division of Neurology 82. Childrens 
Hospital Los Angeles, RO. Box 54700, Los Angeles, CA 90054-0700. 
USA. 
vehicle or 100mg/kg metyrapone (Sigma, St. Louis, 
MO), every 12 h. On the morning of sacrifice, metyrap- 
one was followed, at 09.15 h, by 100 mg/kg aminoglu- 
tethimide. 
Rats were decapitated at 10.00 h and uteri quickly har- 
vested. Maternal and pooled 07 = 5) fetal trunk blood 
was obtained as described previously, and assayed for 
CORT and ACTH [4]. Adult brains and fetal heads were 
frozen immediately on powdered ry ice and kept frozen 
at -80°C. 
Frozen brains were cut into 20/,tin coronal sections 
and mounted on gelatin-coated slides. Brain regions 
were identified by established landmarks [1]. Prior to in 
situ hybridization (ISH), sections were brought to room 
temperature, air-dried and fixed for 20 rain in fresh 4% 
buffered PBS-paraformaldehyde. Sections were dehy- 
drated through increasing ethanol concentrations, rehy- 
drated, exposed to 0.5% acetic anhydride 0.1 M trietha- 
nolamine (pH=8), then dehydrated through 100% etha- 
nol [2, 3]. 
Details of oligonucleotide probe generation and of 
ISH, modified from Young [19], have been described [2, 
3]. Briefly, prehybridization for I h in hybridization 
buffer lacking dextran sulfate (0.2 ml/slice), was followed 
by a 20 h ISH at 40°C [2, 3]. Reaction volume was 
0.03 ml/slice, under a coverslip in a humidity chamber. 
Following serial washes, hybridized sections were proc- 
essed for autoradiography [2, 3]. A 60 nucleotide syn- 
thetic probe corresponding to the codons for the 20 
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Fig. 1. Plasma ACTH in pregnant rats treated with metyrapone for 
48 h. Pharmacological drenalectomy was achieved by mctyrapone in- 
jections (see text). ACTH levels of treated animals were significantly 
different from those of controls: P<0.05. 
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Fig. 2. Toxicity of metyrapone, given ['or 48 72 h. as a function of 
gestational day in pregnant rat and fetuses. Day of sacrifice is indicated. 
Number of rats are in brackets, +, an additional rat in this group was 
not pregnant. 
COOH-amino acids of CRH [17] was labelled on the 3' 
end with dATp-35S. Specific activity of labelled probes 
was 5-8 x 108 dpm//tg. The complementary 'sense' strand 
was similarly generated and labelled. 
Serial sections of the hypothalamus at the level of the 
paraventricular nucleus (PVN) were examined. For 
quantitative studies, 5 sections with the maximal CRH 
mRNA, derived from at least 3 rats each from 2 separate 
litters (for fetuses), were compared [2, 3]. Images were 
obtained and optical density (O.D.) determined over the 
PVN and over the parietal cortex as described previously 
[2, 3]. To allow for variability in background (cortex) 
O.D., the O.D. ratio of PVN to parietal cortex was util- 
ized as a measure of CRH-mRNA abundance, and 
means and standard eviations for 10 ratios were deter- 
mined. For adult rats, sections derived from comparable 
levels in the PVN were also dipped in emulsion (NTB-2, 
Kodak), and exposed for 1 week. They were subjected to 
darkfield microscopy and analysis. Brainpaste standards 
were used to ascertain that measurements were in the 
linear range [2]. Analysis of variance (Minitab, Univer- 
sity Park, PA), was used to assess the significance of dif- 
ferences between experimental groups. 
Effect of pharmacological drenalectomy on maternal 
and fetal levels of CORT and A CTH. Plasma ACTH in- 
creased significantly (P<0.05) in metyrapone-treated rats
(Fig. 1). This effect persisted for 72 h. The metyrapone 
regimen decreased plasma CORT levels 85--95%, e.g. 
plasma CORT in treated adults was 5.9 + 1.6/tg/dl, com- 
pared with 30.2 _+ 3.7/tg/dl in controls 48 h after initia- 
tion of the regimen [4]. The reduction in CORT levels 
was maximal by 24 h, and persisted for at least 72 h [4]. 
Toxici O, of the metyrapone regimen as a Jimction o,1' 
pregnancy day. Metyrapone injections were well toler- 
ated by rats on the 14th 17th pregnancy days. Rats 
weighing less than 350 g by day 17 of pregnancy (11/14), 
as well as the two animals found not to be pregnant, 
appeared well (Fig. 2). Abnormal fetal appearance or 
activity, fetal demise or poor maternal activity were seen 
in heavier animals (3/10, day 17) and worsened with pro- 
gression of pregnancy (Fig. 2). Therefore, following 
these preliminary results, no experiments were con- 
ducted beyond the 18th gestational day, to avoid animal 
stress and malaise. Furthermore, CRH-mRNA was ana- 
lyzed only in adult and fetal rats which appeared healthy 
and indistinguishable from DMSO-injected controls in 
terms of weight, activity etc. Only treated adult and fetal 
rats with (pooled, for fetuses) CORT levels lower than 
5 ¢tg/dl were analyzed [18]. 
Effects of metyrapone treatment h7 CRF-mRNA in fetal 
and pregnant rats. At the end of 48 h of metyrapone 
treatment, CRH-mRNA in the PVN of pregnant rats in- 
creased significantly (Fig. 3). In fetal rats aged 17-18 
days, subjected to 48 or 72 h of the regimen, no change in 
CRH-mRNA abundance was evident. Fig. 3 demon- 
strates the quantitative analysis of CRH-mRNA abun- 
dance in pregnant and fetal rats. Metyrapone "pharma- 
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Fig. 3. Effect of metyrapone-injection regimen oil CRH-mRNA in 
PVN of pregnant and fetal rats. Metyrapone was initiated 48 h prior to 
sacrifice. Bars indicate means and standard errors. Control (C) and 
treated (M) fetal values are not statistically significant. Adult treated 
group (M) differs significantly (P<0.05) from control (C). "sense' de- 
notes otigonucleotide complementary to CRH probe, 
217 
Fig. 4. Photomicrographs of the PVN of 18 day fetal rats following ISH with an oligonucleotide complementary to CRH-messenger RNA. A: treated: 
48 h of metyrapone administration. B: control. PVN, paraventricular nucleus. Bar - I ram. See text for details of 1SH. 
cological adrenalectomy' was initiated on the 16th gesta- 
tional day, and animals were sacrificed 48 h later. The 
significant (P<0.05) increase in CRH-mRNA abundance 
in the pregnant adults rats is contrasted with the lack of 
change in CRH-gene expression in the 18 day fetuses. 
Fig. 4 shows photomicrographs of coronal brain sections 
at the level of the PVN, of fetal rats subjected to the same 
regimen. In Fig. 5, control and treated adult PVN are 
shown. Darkfield micrographs of comparable PVN lev- 
els mainly show an increase in intensity of CRH-mRNA 
signal, and not an increase in number of cells expressing 
CRH. 
These experiments provide evidence that significant 
reduction of plasma CORT levels in the fetal rat does not 
result in the expected enhancement of CRH gene expres- 
sion. This is in contradistinction to the reported effect in 
the adult [9, I1, 18, 19], as well as to our findings in 
pregnant rats. CORT levels decreased to 5/ag/dl, levels 
reported in surgically adrenalectomized rats, and result- 
ing in enhanced CRH gene expression in adult animals 
[18]. Specifically, Swanson and Simmons [18] have 
shown that in the adult rat, adrenalectomy results in in- 
creased CRH-mRNA in the PVN within 48 h, while 
other investigators, using either ISH or Northern blot 
analysis, have documented elevation of CRH gent ex- 
pression in the PVN a week t\~llowing adrenalectomy [9,
11, 18]. 
Swanson and Simmons [18] found lhat CORT levels 
greater than 5/ag/dl were necessary for inhibition of 
adrenalectomy-induced increase in CRH-mRNA. Beyer 
Fig. 5. Darkficld photomicrographs of comparable levels of the paraventricular nucleus or" treated (A) and control (B) pregnant ra ts  subjected toISH 
forCRH-mRNA, lncreased number ofgrains per cell is seen in thc trcatcd animal (star). Bar : 1001m3. 
21~ 
et al. [5] reported restoration of control PVN-CRH- 
mRNA with lower CORT levels (2.9/.zg/dl), but utilized 
Northern blot analysis of whole PVN. 
The levels of plasma CORT achieved with the 
metyrapone regimen should result in minimal occupa- 
tion of GC receptors [15]. The enhanced CRH gene ex- 
pression in the pregnant rats suggests that metyrapone- 
induced GC depletion was adequate to eliminate its neg- 
ative feedback on CRH synthesis. Furthermore, non- 
specific stress econdary to the regimen would be ex- 
pected to increase fetal CORT and CRH mRNA [12] 
neither of which was observed. 
Metyrapone administration is associated with the 
stress of injection and handling [8] which, present also in 
vehicle-injected controls, is unlikely to account for in- 
creased CRH-mRNA in the pregnant rats. Metyrapone 
has been shown to accelerate the response of the adreno- 
cortical system to adrenalectomy [8], but this effect, sig- 
nilicant within hours of adrenalectomy, was nol ob- 
served 2 3 days later [8]. The etfective metyrapone dose 
in pregnant rats ( 100 mg/kg) is significantly lower than in 
adult males (200-300 mg/kg) [14]. This fact, as well as the 
correlation of morbidity and body weight, is probably 
secondary to the altered pharmacokinetics of the drug 
during late gestation in the pregnant rat. 
We found no temporal alteration of CRH gene expres- 
sion by pharmacological adrenalectomy in the fetal rat. 
Metyrapone administration starting on the 14th or 15th 
fetal day did not result in an onset of CRH-gene expres- 
sion prior to the reported [2, 7] 17th fetal day (not 
shown). 
Our findings are compatible with the lack of a GC- 
negative feedback effect on CRH-gene expression in the 
fetal rat. GC receptors have been demonstrated by 
Northern blot analysis of total fetal brain RNA [10]. The 
lack of negative feedback may thus be a consequence of 
decreased receptor function [13], or the immaturity of 
transduction mechanisms beyond the steroid-receptor 
complex interaction. 
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